Radical Numerics Launches Omnii-1, a New Generation of Biological AI, as First AI-Designed Phage Therapy Reaches Human Patient
Researchers used Omnii to design a bacteriophage cocktail that was lab-tested and then given to a patient with a drug-resistant infection.
- On Tuesday, October 20, 2026, Radical Numerics launched Omnii-1, a biological AI model that learns across DNA, RNA, proteins and other molecular data. Researchers used the technology to design a bacteriophage administered to a patient with a drug-resistant infection, marking the first AI-designed phage used in humans.
- Radical Numerics developed a system converting 28 types of biological data, including DNA and proteins, into a format AI can learn. This addresses antimicrobial resistance, which caused 1.27 million deaths directly attributable to the condition.
- "Omnii changes what we're searching with," said Dr. Marisa Azad, an infectious diseases physician-scientist at The Ottawa Hospital. Rather than screening thousands of candidates, the AI designs matching phages for resistant strains within weeks.
- The New York Times noted the research is self-published and lacks peer review. Radical Numerics declined to share clinical details about the patient or doctors involved, citing the proprietary nature of the treatment.
- Harvard microbiologist Michael Baym told the New York Times his "impulse is to be skeptical," though he called the concept "incredible." Biodefense advisor Hon emphasized the technology could accelerate responses to emerging biological threats.
28 Articles
28 Articles
A virus created by artificial intelligence has been administered to a patient with an antibiotic-resistant infection, according to an announcement by the American company Radical Numerics. The technology of All-1 could open up new perspectives in the fight against superbacteria, but the result of treatment has not been made public.
The Omnii artificial intelligence model developed viruses that target an intestinal stick resistant to antibiotics and existing bacteria.
AI-designed virus may have just been injected into humans for first time
Radical Numerics claims their AI-driven approach can lead to rapid, on-demand generation of phages
A startup claimed to have first administered artificial intelligence-designed phages to a patient without available therapeutic alternatives
For the first time, scientists claim to have used viruses designed by artificial intelligence to treat a human patient. Researchers have announced that they have administered the virus, known as phage, to a patient suffering from a deadly bacterial infection. phages attack bacteria, and the hope is that it will eliminate the microbes causing the infection. 'I am traumatized': doctor explains how the phrase has turned the new trend in psychology …
Coverage Details
Bias Distribution
- 43% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium





















